Syngene International Share Price
Small Cap | Pharmaceuticals and health care | NSE: SYNGENE | BSE: 539268
₹709.70 
-5.20 (-0.73 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 714.60
High (₹) 725.50
Low (₹) 705.00
Prev. Close (₹) 714.90
Volume 7,338
VWAP (₹) 714.60
ROCE (%) 13.56
Industry P/E 61.12
TTM P/E 56.96
P/B Ratio 6.74
Market Cap (₹) Cr.28,731.08
Dividend Yield (%)0.18
EPS (₹) 12.69
ROE11.98%
Sales Growth (%) 9.26
Profit Growth (%)9.82
Day Range
725.50725.50
52 Week Range
608.00960.00
Historical Returns
Returns (6M)
-16.89 %
Returns (1Y)
-4.51 %
Returns (3Y)
29.33 %
Returns (5Y)
133.26 %
Returns (6M)
-16.89 %
Returns (1Y)
-4.51 %
Returns (3Y)
29.33 %
Returns (5Y)
133.26 %
SWOT Analysis
- Company with (10.25%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 10.25% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 57.34
MFI 95.30
ATR 21.30
Commodity Channel Index -48.05
ROC125 -15.19
ROC21 -10.30
Williams %R -54.26
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 724.64 | 735.32 | 745.14 | 714.82 | 704.14 | 694.32 | 683.64 |
| Week Ago | 705.65 | 720.60 | 731.25 | 695.00 | 680.05 | 669.40 | 654.45 |
| Month Ago | 840.21 | 848.33 | 855.31 | 833.23 | 825.11 | 818.13 | 810.01 |
EMA & SMA
709.70
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
16
5 Day 705.21
9 Day 710.04
10 Day 714.51
12 Day 722.14
14 Day 722.31
20 Day 729.60
26 Day 753.56
50 Day 800.79
100 Day 842.16
200 Day 806.67
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BIOCON LIMITED | bulk | Sell | 10 Dec, 2024 | ₹857.68 | 80,00,000 | BSE |
| BIOCON LIMITED | block | Sell | 01 Feb, 2023 | ₹560.00 | 2,39,100 | BSE |
| WHITE OAK CAPITAL MANAGEMENT CONSULTANTS LLP | block | Buy | 01 Feb, 2023 | ₹560.00 | 3,42,355 | BSE |
| UTI MID CAP FUND | block | Buy | 01 Feb, 2023 | ₹560.00 | 1,92,500 | BSE |
| UTI - PHARMA AND HEALTHCARE FUND | block | Buy | 01 Feb, 2023 | ₹560.00 | 57,500 | BSE |
| UNION MUTUAL FUND | block | Buy | 01 Feb, 2023 | ₹560.00 | 47,111 | BSE |
| TARA EMERGING ASIA LIQUID FUND | block | Buy | 01 Feb, 2023 | ₹560.00 | 6,00,000 | BSE |
| SUN LIFE EXCEL INDIA FUND | block | Buy | 01 Feb, 2023 | ₹560.00 | 1,42,857 | BSE |
| STWRT INVT GLBL EMG MKT SUSTNBLTY FD AS SB FD OF FIRST ST GLBL UMB FD PLC | block | Buy | 01 Feb, 2023 | ₹560.00 | 1,33,934 | BSE |
| STWRT INVESTRS ASIA PAC SUSTANBLTY FD AS SB FD OF FIRST ST GLBL UMB FD PLC | block | Buy | 01 Feb, 2023 | ₹560.00 | 1,06,153 | BSE |
| STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOL | block | Buy | 01 Feb, 2023 | ₹560.00 | 3,04,000 | BSE |
| BIOCON LIMITED | bulk | Sell | 01 Feb, 2023 | ₹560.00 | 4,00,00,000 | BSE |
| GOVERNMENT OF SINGAPORE | bulk | Buy | 01 Feb, 2023 | ₹560.00 | 1,57,99,200 | BSE |
| BIOCON LIMITED | bulk | Sell | 06 Sept, 2022 | ₹560.04 | 2,17,89,164 | BSE |
| ICICI PRUDENTIAL MUTUAL FUND | bulk | Buy | 06 Sept, 2022 | ₹560.00 | 28,28,510 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 27 Dec, 2024 | ANJAN CHAKRABARTI | Disposal | ₹850.5899838449111470113085622 | 6,190 | BSE |
| 23 Dec, 2024 | ANJAN CHAKRABARTI | Acquisition | ₹859.7300051378660729576982360 | 58,390 | BSE |
| 23 Dec, 2024 | ANJAN CHAKRABARTI | Disposal | ₹843.54 | 27,200 | BSE |
| 11 Dec, 2024 | BIOCON LIMITED | Disposal | ₹857.68 | 80,00,000 | BSE |
| 28 Nov, 2024 | DEEPAK VENKATRAMAN | Disposal | ₹889.35 | 600 | BSE |
| 28 Nov, 2024 | MAYANK VERMA | Disposal | ₹913.17 | 1,500 | BSE |
| 28 Nov, 2024 | DEEPAK VENKATRAMAN | Disposal | ₹907.15 | 600 | BSE |
| 18 Nov, 2024 | ALOK MEHROTRA | Disposal | ₹858.22 | 8,200 | BSE |
| 18 Nov, 2024 | ALOK MEHROTRA | Acquisition | ₹876.03 | 20,000 | BSE |
| 11 Nov, 2024 | SIBAJI BISWAS | Disposal | ₹913.64 | 35,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 24 Apr, 2024 | Rs.1.2500 per share(12.5%)Final Dividend | 28 Jun, 2024 | 28 Jun, 2024 |
| 26 Apr, 2023 | Rs.0.5000 per share(5%)Final Dividend | 30 Jun, 2023 | 30 Jun, 2023 |
| 28 Apr, 2022 | Rs.0.5000 per share(5%)Special Dividend | 30 Jun, 2022 | 01 Jul, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 21 Feb, 2025 | BSE India | Update on pre-approval and cGMP inspection by United States Food & Drug Administration (USFDA) |
| 15 Feb, 2025 | NSE India | Syngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company |
| 11 Feb, 2025 | NSE India | SYNGENE INTERNATIONAL LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 10 Feb, 2025 | NSE India | Syngene International Limited has informed the Exchange about intimation of cancellation of meetings with Analysts/Institutional Investors |
| 10 Feb, 2025 | BSE India | Intimation of cancellation of meetings with Analysts/Institutional Investors. |
| 10 Feb, 2025 | NSE India | Syngene International Limited has informed the Exchange about change in Management |
| 10 Feb, 2025 | BSE India | Intimation of Leadership changes. |
| 10 Feb, 2025 | BSE India | Intimation of Leadership changes. |
| 10 Feb, 2025 | NSE India | Syngene International Limited has informed the Exchange regarding a press release dated February 10, 2025, titled ""Syngene International announces Leadership changes"". |
| 10 Feb, 2025 | BSE India | Press release titled \Syngene International announces Leadership changes\ |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 14 Jan, 2025 | 23 Jan, 2025 |
| Quarterly Results | -- | 07 Oct, 2024 | 23 Oct, 2024 |
| Quarterly Results | -- | 01 Jul, 2024 | 24 Jul, 2024 |
| Audited Results & Final Dividend | -- | 02 Apr, 2024 | 24 Apr, 2024 |
| Quarterly Results | -- | 27 Dec, 2023 | 25 Jan, 2024 |
| Quarterly Results | -- | 10 Oct, 2023 | 17 Oct, 2023 |
| Quarterly Results | -- | 14 Jul, 2023 | 26 Jul, 2023 |
| Audited Results & Final Dividend | -- | 11 Apr, 2023 | 26 Apr, 2023 |
| Quarterly Results | -- | 09 Jan, 2023 | 23 Jan, 2023 |
| Quarterly Results | -- | 07 Oct, 2022 | 19 Oct, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Syngene International
Syngene International is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937. Currently Company is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 3203.10 Cr. and Equity Capital is Rs. 402.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Jonathan Hunt
NSE Symbol
SYNGENE
Syngene International Management
| Name | Designation |
|---|---|
| Ms. Kiran Mazumdar Shaw | Non Executive Chairman |
| Mr. Jonathan Hunt | Managing Director & CEO |
| Mr. Sibaji Biswas | Executive Director & CFO |
| Prof. Catherine Rosenberg | Non Executive Director |
| Dr. Kush Parmar | Independent Director |
| Mr. Paul Blackburn | Independent Director |
| Ms. Sharmila Abhay Karve | Independent Director |
| Dr. Vijay Kuchroo | Independent Director |
| Mr. Nilanjan Roy | Independent Director |
| Ms. Vinita Bali | Lead Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Syngene Intl | ₹34,229.73 | ₹713.75  ₹714.60(-0.12%) | ₹608.000 - ₹960.000 |
| SPARC | ₹6,538.46 | ₹129.43 ₹135.25(-4.30%) | ₹189.450 - ₹474.000 |
| Suven Life | ₹2,798.32 | ₹117.60 ₹118.45(-0.72%) | ₹80.100 - ₹169.000 |
| Vimta Labs | ₹2,215.44 | ₹946.75 ₹965.65(-1.96%) | ₹400.150 - ₹1,070.550 |
| Choksi Labs | ₹45.34 | ₹129.00 ₹131.50(-1.90%) | ₹38.320 - ₹94.000 |
FAQs on Syngene International
What is the share price of Syngene International?
The share price of Syngene International on 21 Feb, 2025 is ₹ 709.70.
What is 52W high and 52W low share price of Syngene International?
The highest and lowest 52W share prices of Syngene International are ₹ 960.000 and ₹ 608.000
What is the market cap of Syngene International?
The market capitalization of Syngene International as of 21 Feb, 2025 is ₹ 28,731.08 Crores
What is the P/E ratio of Syngene International?
The current P/E ratio of Syngene International as of 21 Feb, 2025 is 61.12
What is the PB ratio of Syngene International?
The PB ratio of Syngene International as of 21 Feb, 2025 is 6.74
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)